News

Agilon Health missed the consensus estimate for adjusted EPS in its fourth-quarter 2024 earnings report, but its revenue met expectations. J.P. Morgan analyst Lisa C. Gill revised her estimates for the company, reflecting an updated outlook on its recovery timeline based on management's recent commentary.

Strategy Inc. (MSTR) has been a wild ride for investors, surging 90.7% over the past year but slipping 4.48% year-to-date. Now, as the stock struggles below its key moving averages, the debate over its future is heating up, featuring none other than Michael Saylor and Peter Schiff in opposing corners.

French MEP Raphael Glucksmann, while expressing gratitude for American sacrifices during World War II, criticized the current administration's policies, particularly regarding Russia and Ukraine. He suggested a betrayal of democratic values and compared the bravery of American heroes during the war with the current administration's approach, which he believes undermines the values of freedom and democracy that the United States once champ...

Strategy Inc. (MSTR) has experienced a turbulent year, surging 90.7% in the past year but slipping 4.48% year-to-date. The stock's performance is closely tied to the volatile cryptocurrency market, particularly Bitcoin, with prominent figures like Michael Saylor and Peter Schiff offering opposing perspectives on its future.

Cathie Wood's Ark Invest made significant trades on Tuesday, acquiring shares in Tempus AI and AMD while selling shares in Meta Platforms. These moves reflect Ark's confidence in the growth potential of AI and GPU companies, while also suggesting concerns about Meta's valuation and regulatory challenges.